FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
Links shared publicly online about this topic.
- 1,464total visits
FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
View full resource at medicalnewstoday.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug, FDA, Actemra, Roche Pharmaceuticals, Genentech
Most Recently Shared on January 11, 2010 at 5:07 pm By:
FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis http://mnt.to/3w8r
ACTEMRA (tocilizumab) | Rheumatoid Arthritis Treatment
actemra.com — “Find information about ACTEMRA, an FDA-approved treatment for rheumatoid arthritis. ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well. ACTEMRA is used to treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older. So” View full resource at actemra.com
Most Recently Shared on January 20, 2012 at 3:35 pm By:
American Autoimmune Related Diseases Association (AARDA) Statement On The FDA Approval Of A New Treatment For Rheumatoid Arthritis
medicalnewstoday.com — “Friday, january 8, 2010, the food and drug administration (fda) approved actemra® (tocilizumab), a new biologic response modifier for adult patients with moderately to severely active rheumat” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2010 at 3:11 pm By:
MNT Arthritis News Health News
American Autoimmune Related Diseases Association (AARDA) Statement On The FDA Approval Of A New Treatment For Rheumato... http://mnt.to/3wdR
American Autoimmune Related Diseases Association (AARDA) Statement on the FDA Approval of a New Treatment for Rheumatoid Arthritis
newswise.com — “Friday, January 8, 2010, the Food and Drug Administration (FDA) approved ACTEMRA (tocilizumab), a new biologic response modifier for adult patients with moderately to severely active rheumatoid arthritis (RA).” View full resource at newswise.com
Most Recently Shared on January 12, 2010 at 9:26 pm By:
American Autoimmune Related Diseases Association (AARDA) Statement on the FDA Approval of a New Treatment for Rheu... http://bit.ly/5nFgFQ
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 12, 2010 at 12:27 am By:
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis - http://bit.ly/8vWion
Actemra approved for moderately to severely active rheumatoid arthritis - MPR
empr.com — “The FDA has approved Actemra (tocilizumab, from Roche) for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.” View full resource at empr.com
Most Recently Shared on January 11, 2010 at 3:00 pm By:
MPR News: Actemra approved for moderately to severely active rheumatoid arthritis: The FDA has approved Actemra (t... http://bit.ly/8WioYm
FDA Approves ACTEMRA for the Treatment of Moderately to Severely Active Rheumatoid Arthritis | Pharmaceutical Processing
pharmpro.com — “Roche today announced that the FDA approved ACTEMRA (tocilizumab, RoACTEMRA in the European Union) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.” View full resource at pharmpro.com
Most Recently Shared on January 11, 2010 at 1:27 pm By:
RT @PharmProEditor: #FDA Approves ACTEMRA for the Treatment of Moderately to Severely Active Rheumatoid Arthritis http://bit.ly/5AiTH4
Advertisement
